Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,279,345
-
Share change
-
+2,548,600
-
Total reported value
-
$454,194,890
-
Price per share
-
$15.00
-
Number of holders
-
71
-
Value change
-
+$38,539,453
-
Number of buys
-
42
-
Number of sells
-
18
Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q3 2016
As of 30 Sep 2016 AIMMUNE THERAPEUTICS INC - COM (AIMT) had 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,279,345 shares of stock of the company.
Largest 10 holders included FMR LLC, Foresite Capital Management II, LLC, Aisling Capital LLC, TLP GROUP LLC, EAGLE ASSET MANAGEMENT INC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., and Foresite Capital Management III, LLC.
This table shows 71 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.